Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Hypoparathyroidism
In brief
The purpose of this study is to evaluate the long-term safety and tolerability of MBX 2109 in patients with hypoparathyroidism who completed the 12-week treatment period in the Phase 2 study, MBX-2H1002.
Key facts
- Study ID
- NCT06531941
- Run by
- MBX Biosciences
- People needed
- 60
- Starts
- 2024-10-31
- Expected to finish
- 2027-05-27
- Last updated by the study team
- 2025-10-28
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- MBX Biosciences Investigational Site — Miami, Florida, United States
- MBX Biosciences Investigational Site — Macon, Georgia, United States
- MBX Biosciences Investigational Site — Jackson, Mississippi, United States
- MBX Biosciences Investigational Site — St Louis, Missouri, United States
- MBX Biosciences Investigational Site — Las Vegas, Nevada, United States
- MBX Biosciences Investigational Site — Reno, Nevada, United States
- MBX Biosciences Investigational Site — Albany, New York, United States
- MBX Biosciences Investigational Site — New York, New York, United States
- MBX Biosciences Investigational Site — The Bronx, New York, United States
- MBX Biosciences Investigational Site — Columbus, Ohio, United States
- MBX Biosciences Investigational Site — Dallas, Texas, United States
- MBX Biosciences Investigational Site — El Paso, Texas, United States
- MBX Biosciences Investigational Site — Fort Worth, Texas, United States
- MBX Biosciences Investigational Site — Round Rock, Texas, United States
- MBX Biosciences Investigational Site — San Antonio, Texas, United States
- MBX Biosciences Investigational Site — Weslaco, Texas, United States
- MBX Biosciences Investigational Site — Madison, Wisconsin, United States
- MBX Biosciences Investigational Site — Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- MBX Biosciences Investigational Site — Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- MBX Biosciences Investigational Site — Córdoba, Río Cuarto, Argentina
- MBX Biosciences Investigational Site — Córdoba, Argentina
- MBX Biosciences Investigational Site — San Miguel de Tucumán, Argentina
- MBX Biosciences Investigational Site — Samsun, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.